Brookfield Corp’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-30,230
Closed -$381K 560
2023
Q2
$381K Sell
30,230
-4,407
-13% -$53.5K ﹤0.01% 521
2023
Q1
$452K Sell
34,637
-20,146
-37% -$326K ﹤0.01% 585
2022
Q4
$966K Sell
54,783
-110,733
-67% -$1.86M ﹤0.01% 507
2022
Q3
$2.52M Sell
165,516
-309,649
-65% -$5.01M 0.01% 410
2022
Q2
$7.05M Sell
475,165
-132,240
-22% -$2.47M 0.03% 198
2022
Q1
$13.7M Buy
607,405
+307,119
+102% +$6.22M 0.05% 124
2021
Q4
$5.54M Buy
+300,286
New +$4.77M 0.02% 201

Other funds holding MDRX

Brookfield Corp's MDRX Position: Q3 2023 in Review

Brookfield Corp sold out of Veradigm Inc. Common Stock (MDRX) in Q3 2023, closing a stake of 30,230 shares — an estimated $381K sold.

Brookfield Corp first reported a position in MDRX in Q4 2021 and held it in 7 quarters. The position peaked at $13.7M in Q1 2022. 216 funds tracked by Wall St. Rank hold MDRX as of Q3 2023.

  • Brookfield Corp reported no remaining Veradigm Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 30,230 Veradigm Inc. Common Stock shares in Q3 2023, an estimated $381K.
  • Brookfield Corp first reported a position in Veradigm Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • Brookfield Corp's Veradigm Inc. Common Stock position peaked at $13.7M in Q1 2022.
  • 216 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.